Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin

NCT04549363 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class

Stopped The study has been terminated for reasons pertaining to feasibility

Conditions

Interventions

Sponsor

GlaxoSmithKline